Evidence map›Paper›PMID 26230333›Full record

ArticlePloS one2015

Effect of Twice-Daily Blue Light Treatment on Matrix-Rich Biofilm Development.

Denise Lins de Sousa, Ramille Araújo Lima, Iriana Carla Zanin, Marlise I Klein, Malvin N Janal, Simone Duarte

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. A Standardized Mouse Model for Wound Infection withInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Trans-Cinnamaldehyde-FightingPharmaceutics · 2024
    Article
  10. Review
  11. Review
  12. Antibacterial and Antiviral Properties ofFoods (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Anti-Bacterial Properties of Cannabigerol TowardFrontiers in microbiology · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Denise Lins de SousaDepartment of Dental Clinics, School of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil.
Ramille Araújo LimaDepartment of Dental Clinics, School of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil.
Iriana Carla ZaninDepartment of Dental Clinics, School of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil.
Marlise I KleinDepartment of Biomaterials, State University of São Paulo, Araraquara, São Paulo, Brazil.
Malvin N JanalDepartment of Epidemiology and Health Promotion, College of Dentistry, New York University, NYU, New York, United States of America.
Simone DuarteDepartment of Basic Science and Craniofacial Biology, College of Dentistry, New York University, New York, United States of America.
Universidade Federal do Ceará · BRNew York University · USUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of blue light has been proposed as a direct means of affecting local bacterial infections, however the use of blue light without a photosensitizer to prevent the biofilm development has not yet been explored. The aim of this study was to determine how the twice-daily treatment with blue light affects the development and composition of a matrix-rich biofilm. METHODOLOGY/PRINCIPAL

findingsBiofilms of Streptococcus mutans UA159 were formed on saliva-coated hydroxyapatite discs for 5 days. The biofilms were exposed twice-daily to non-coherent blue light (LumaCare; 420 nm) without a photosensitizer. The distance between the light and the sample was 1.0 cm; energy density of 72 J cm-2; and exposure time of 12 min 56 s. Positive and negative controls were twice-daily 0.12% chlorhexidine (CHX) and 0.89% NaCl, respectively. Biofilms were analyzed for bacterial viability, dry-weight, and extra (EPS-insoluble and soluble) and intracellular (IPS) polysaccharides. Variable pressure scanning electron microscopy and confocal scanning laser microscopy were used to check biofilm morphology and bacterial viability, respectively. When biofilms were exposed to twice-daily blue light, EPS-insoluble was reduced significantly more than in either control group (CHX and 0.89% NaCl). Bacterial viability and dry weight were also reduced relative to the negative control (0.89% NaCl) when the biofilms were treated with twice-daily blue light. Different morphology was also visible when the biofilms were treated with blue light.

conclusionsTwice-daily treatment with blue light without a photosensitizer is a promising mechanism for the inhibition of matrix-rich biofilm development.

Indexed as

LightBiofilmsChlorhexidinePolysaccharidesSodium ChlorideStreptococcus mutansChlorhexidinePolysaccharidesSodium Chloride

Identifiers

PMID26230333
PMCPMC4521953
OpenAlexW1958027862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.